(Reuters) -Contract research organizations are reporting better-than-expected second-quarter profit, a sign that Wall Street analysts say reflects a rebound in biotech and pharmaceutical spending ...
Nov 6 (Reuters) - Charles River Laboratories (CRL.N), opens new tab raised its full-year profit forecast after beating analysts' estimates for quarterly results as the contract research firm expects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback